Zobrazeno 1 - 10
of 52
pro vyhledávání: '"L. Benazzato"'
Publikováno v:
ESGE Days 2019.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51b42873292282b2a5fa12548d22270b
https://doi.org/10.1055/s-0039-1681601
https://doi.org/10.1055/s-0039-1681601
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alessandro Lavagna, Andrea Cassinotti, Gianmichele Meucci, F. Mocciaro, C. Morselli, Daniela Scimeca, R. Sostegni, Mario Cottone, E. Angelucci, Ambrogio Orlando, R. Cosintino, Livia Biancone, Alessandra Geremia, Fernando Rizzello, Anna Kohn, Antonio Rispo, Fabrizio Bossa, Gabriele Riegler, L. Benazzato, Claudio Papi, Fabiana Castiglione, Enrico Colombo, Angelo Viscido
Publikováno v:
Digestive and Liver Disease. 37:577-583
Background. Almost 20% of patients with active Crohn's disease are refractory to conventional therapy. Infliximab is a treatment of proven efficacy in this group of patients and it is not clear which variables predict a good response. Aims. To evalua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2355a35031104faa43e4f5d05bad9c93
https://doi.org/10.1016/j.dld.2005.01.019
https://doi.org/10.1016/j.dld.2005.01.019
Publikováno v:
Digestive and Liver Disease. 50:e69
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c503d453943b4dca8be21253bc8af609
https://doi.org/10.1016/s1590-8658(18)30270-6
https://doi.org/10.1016/s1590-8658(18)30270-6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jaime San Pio Rodriguez, Pia Munkholm, Margarita Elkjaer, Lotte Dinesen, L. Benazzato, Vibeke Logager Løgager
Publikováno v:
Journal of Crohn's and Colitis. 2:241-245
Background The association of Crohn's disease with Fistulizing Hidradenitis Suppurativa (FHS) was established in the 90s. FHS is a chronic disease, characterized by the formation of multiple abscesses and sinus tracts in apocrine gland-bearing areas.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94cf3ed03e2be52202f34579c1d9b5f3
https://doi.org/10.1016/j.crohns.2008.02.002
https://doi.org/10.1016/j.crohns.2008.02.002
Autor:
Francesco Pallone, Emma Calabrese, R. Sostegni, Livia Biancone, Claudio Papi, Fabiana Castiglione, Enrico Colombo, E. Angelucci, Fernando Rizzello, Gianmichele Meucci, Anna Kohn, Carmelina Petruzziello, Mario Cottone, Alessandra Geremia, Ambrogio Orlando, Gabriele Riegler, L. Benazzato, F. Mocciaro
Publikováno v:
Gut. 55:228-233
BACKGROUND AND AIMS: The widespread use of anti-tumour necrosis factor alpha antibody (Infliximab) in Crohn's disease (CD) raises concerns about a possible cancer risk in the long term. In a matched pair study, we assessed whether Infliximab is assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8650521e58451e0ba7e0ea126dd12cd0
https://doi.org/10.1136/gut.2005.075937
https://doi.org/10.1136/gut.2005.075937
Autor:
G. G. Sturniolo, Francesco Grigoletto, Egle Perissinotto, Renata D'Incà, L. Benazzato, Imerio Angriman, Valentina Medici
Publikováno v:
Digestive and Liver Disease. 36:461-466
Background. Severe attacks of ulcerative colitis have a high risk of colectomy. Aims. To evaluate the effects of standard medical management and to identify the clinical and laboratory variables capable of predicting the clinical outcome. Materials a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea4d9607e164f286902d511e12057ed2
https://doi.org/10.1016/j.dld.2003.12.017
https://doi.org/10.1016/j.dld.2003.12.017
Autor:
A. Di Sabatino, Giacomo Carlo Sturniolo, Gino Roberto Corazza, Rachele Ciccocioppo, L. Benazzato
Publikováno v:
Alimentary Pharmacology & Therapeutics. 19:1019-1024
Summary Background : The use of infliximab in the treatment of Crohn's disease patients with symptomatic stenosis is controversial. Aim : To explore the influence of this agent on intestinal fibrogenesis by measuring in infliximab-treated Crohn's dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ceac8c48a8aea889fe0a7fb5b19f66f
https://doi.org/10.1111/j.1365-2036.2004.01927.x
https://doi.org/10.1111/j.1365-2036.2004.01927.x
Autor:
Renata D'Incà, Romilda Cardin, Giacomo Carlo Sturniolo, Imerio Angriman, L. Benazzato, Diego Martines
Publikováno v:
Inflammatory Bowel Diseases. 10:23-27
Background: Chronic inflammation may contribute to cancer risk through the accumulation of specific products as a result of DNA damage. The role of free radical mediated oxidative DNA damage during inflammation was determined in patients with ulcerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb77b01d272ab9208a879aa40a364f9b
https://doi.org/10.1097/00054725-200401000-00003
https://doi.org/10.1097/00054725-200401000-00003